Human CA13 PharmaGenie ELISA Kit (SBRS0336)

Carbonic anhydrase 13 (CA13) is a cytosolic zinc metalloenzyme that catalyzes the reversible conversion of carbon dioxide to bicarbonate, and altered CA13 expression has been investigated in research ranging from tissue-specific profiling to exploratory biomarker studies. The Assay Genie Human CA13 PharmaGenie ELISA Kit provides a microplate-based immunoassay workflow for quantitative measurement of human carbonic anhydrase 13, supplied in a kit configuration sufficient for 96 individual reactions on a standard plate reader. The assay is intended for in vitro research use only and supports investigations into carbonic anhydrase family biology, gene expression patterns, and potential disease associations across multiple human sample matrices. Unopened components are shipped under refrigerated conditions, and reagents should be equilibrated to room temperature before running the assay to ensure consistent signal development. Each kit includes a pre-coated plate, detection reagents, calibrated standards, and wash and assay buffers, allowing laboratory teams to generate standardized, reproducible results in studies of cytosolic carbonic anhydrase activity and regulation.